Longevity Biotech
Avery Zucco is a scientist at Longevity Biotech, where responsibilities include designing and performing experiments in cell and molecular biology for clinical trial protocols. Previous experience includes serving as a Clinical Genomic Scientist at Children's Hospital of Philadelphia, focusing on pediatric genetic diagnostics and workflow enhancements. Prior roles include a Postdoctoral Researcher at The Wistar Institute, where iPSC-based models were established, and a Graduate Research Assistant at Rutgers University, involved in neurodevelopmental research and teaching biology. Educational background features a PhD in Neuroscience and Cell Biology from Rutgers University and a BS in Neuroscience from Temple University.
This person is not in any teams
Longevity Biotech
Longevity Biotech is developing a new class of therapeutic candidates called Hybridtides. Their focus is on delivering clinically transformative products that tackle the most challenging aspects of medicine today.